Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of investigational allergology & clinical immunology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 21370724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An update on the role of leukotrienes in asthma

  2010cited by this paper
• The role of neurotrophins in the pathophysiology of allergic rhinitis

  2010cited by this paper
• Upper airway. 3: Sinonasal involvement in chronic obstructive pulmonary disease

  2010cited by this paper
• Effects of fexofenadine on inflammatory mediators in nasal lavage fluid in intermittent allergic rhinitis.

  2009cited by this paper
• The Editor's Choice

  2008cited by this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 *

  2008cited by this paper
• Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review

  2008cited by this paper
• A review of nasal polyposis

  2008cited by this paper
• Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase

  2007cited by this paper
• Expression of 5‐lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin‐intolerant asthma

  2006influential reference
• Neurogenic mechanisms in bronchial inflammatory diseases

  2004cited by this paper
• Molecular and functional aspects of human cysteinyl leukotriene receptors.

  2004cited by this paper
• Nasal polyposis: an update

  2003cited by this paper
• Eosinophils and cysteinyl leukotrienes.

  2003influential reference
• Nasal polyps: Still more questions than answers

  2003cited by this paper
• The Role of Leukotrienes in Nasal Allergy

  2003cited by this paper
• The influence of inhalative corticosteroids on circulating Nerve Growth Factor, Brain‐Derived Neurotrophic Factor and Neurotrophin‐3 in allergic asthmatics

  2001cited by this paper
• An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma

  2001cited by this paper
• Acute Effects of Antileukotrienes on Sinonasal Polyposis and Sinusitis

  2000cited by this paper
• Aspirin-induced asthma: advances in pathogenesis and management.

  1999cited by this paper
• Quality of life in nasal polyposis.

  1999cited by this paper
• Topical budesonide treatment reduces endothelial expression of intercellular adhesion molecules (vascular cell adhesion molecule-1 and P-selectin) and eosinophil infiltration in nasal polyps.

  1999cited by this paper
• Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.

  1998cited by this paper
• IL-5 synthesis is upregulated in human nasal polyp tissue.

  1997cited by this paper
• Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.

  1995cited by this paper
• Airway responsiveness to leukotriene C4 (LTC4), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjects.

  1993cited by this paper
• Current concepts in the surgical management of nasal polyposis.

  1992cited by this paper
• The role of leukotrienes in allergic rhinitis: a review.

  1991influential reference
• Nasal polyposis.

  1990cited by this paper
• Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

  1983cited by this paper

• Chinese Guidelines for Diagnosis and Treatment of Chronic Rhinosinusitis (2024)

  2025cites this paper
• Poliposis nasosinusal, rinosinusitis crónica con pólipos

  2024cites this paper
• Polypose nasosinusienne, rhinosinusite chronique avec polypes

  2024cites this paper
• Poliposi nasosinusale, rinosinusite cronica con polipi

  2024cites this paper
• Update on the Role of Fungus in Allergy, Asthma, and the Unified Airway.

  2023cites this paper
• Assessment of Pain Management After Orthognathic Surgery by the Administration of Montelukast: An Original Research

  2023cites this paper
• Unified Airway Disease: Future Directions.

  2023cites this paper
• Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic Frontiers

  2023cites this paper
• Asthma Management Considerations for the Otolaryngologist: Current Therapies.

  2023cites this paper
• Effects of Montelukast on Arsenic-Induced Epithelial-Mesenchymal Transition and the Role of Reactive Oxygen Species Production in Human Bronchial Epithelial Cells

  2022cites this paper
• Unified Airway Disease: Examining Prevalence and Treatment of Upper Airway Eosinophilic Disease with Comorbid Asthma.

  2022cites this paper
• Montelukast induces beneficial behavioral outcomes and reduces inflammation in male and female rats

  2022cites this paper
• What Is the Effect of Pre-Emptive Oral Montelukast on Postoperative Pain Following Bimaxillary Orthognathic Surgery? A Triple-Blind Randomized Clinical Trial.

  2021cites this paper
• A Double-Blind Randomized Controlled Trial on the Effects of Montelukast on the Serum Level Of Inflammatory Factors in Patients with Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Eosinophilic and non-eosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort.

  2021cites this paper
• Eosinophilic and Noneosinophilic Asthma

  2021cites this paper
• Management of chronic rhinosinusitis with nasal polyps in Samter triad by low-dose ASA desensitization or dupilumab

  2021cites this paper
• Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial

  2021cites this paper
• International consensus statement on allergy and rhinology: rhinosinusitis 2021

  2020cites this paper
• Asthma and Chronic Rhinosinusitis: Origins and Pathogenesis

  2020cites this paper
• Chinese Society of Allergy and Chinese Society of Otorhinolaryngology-Head and Neck Surgery Guideline for Chronic Rhinosinusitis

  2020cites this paper
• The Unified Airway: Rhinologic Disease and Respiratory Disorders

  2020cites this paper
• Fibrodysplasia ossificans progressiva: current concepts from bench to bedside

  2020cites this paper
• β 2 AGONIST VERSUS CYSTEINYL LEUKOTRIENE RECEPTOR ANTAGONIST IN CHRONIC ASTHMA PATIENTS

  2019cites this paper
• Chronic Rhinosinusitis: Adults and Children

  2019cites this paper
• Evidence-Based Treatment on Nasal Polyposis

  2019cites this paper
• Substance P and Hemokinin 1 in Nasal Lavage Fluid of Patients with Chronic Sinusitis and Nasal Polyposis

  2019cites this paper
• Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases.

  2019cites this paper
• Nasal cytology: Methodology with application to clinical practice and research

  2018cites this paper
• Current opinions for the management of asthma associated with ear, nose and throat comorbidities

  2018cites this paper
• The leukotriene receptor antagonist pranlukast attenuates airway remodeling by suppressing TGF-β signaling.

  2018cites this paper
• Expression of cysteinyl leukotriene receptor GPR17 in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps.

  2018cites this paper
• The effect of levocetirizine and montelukast on clinical symptoms, serum level and skin expression of COX-1 and COX-2 enzymes in patients suffering from chronic autoimmune urticaria – a pilot study

  2018cites this paper
• Lack of long‐term add‐on effect by montelukast in postoperative chronic rhinosinusitis patients with nasal polyps

  2018cites this paper
• Justicia pectoralis, a coumarin medicinal plant have potential for the development of antiasthmatic drugs?

  2017cites this paper
• [Knowledge and attitudes about aspirin exacerbated respiratory disease among Ecuadorian physicians].

  2017cites this paper
• [The role of a leukotriene receptor antagonist in the restoration of the nasal breathing in the patients presenting with polypous rhinosinusitis].

  2017cites this paper
• Effect of Postoperative Montelukast on Chronic Rhinosinusitis with Polyposis Recurrence Following Functional Endoscopic Sinus Surgery

  2017cites this paper
• Therapeutic Effect of Montelukast for Treatment of Uremic Pruritus in Hemodialysis Patients.

  2017cites this paper
• Nasal polyposis and asthma: the chest physician's view

  2017cites this paper
• Treating the nose for controlling the lung: a vanishing story?

  2017cites this paper
• Leitlinie „Rhinosinusitis“ – Langfassung

  2017cites this paper
• Chronic rhinosinusitis: the rationale for current treatments

  2017cites this paper
• Inflammatory Mediators and Neuromodulators: Targeting in Asthma and Chronic Obstructive Pulmonary Disease

  2016cites this paper
• International Consensus Statement on Allergy and Rhinology: Rhinosinusitis

  2016cites this paper
• Outcomes in Medical and Surgical Treatment of Nasal Polyps.

  2016cites this paper
• Oral Therapeutics for Rhinosinusitis with Nasal Polyposis.

  2016cites this paper
• Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin‐exacerbated respiratory disease: an evidence‐based review with recommendations

  2016cites this paper
• Effectiveness of leukotriene receptor antagonism in the postoperative management of chronic rhinosinusitis

  2016cites this paper
• Association and management of eosinophilic inflammation in upper and lower airways.

  2015cites this paper
• Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents: a systematic review and meta-analysis.

  2015cites this paper
• Modulation des mécanismes inflammatoires impliquant les polynucléaires éosinophiles au cours de la polypose naso-sinusienne associée à l'asthme

  2015cites this paper
• Management of Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma: A Systematic Review

  2015cites this paper
• Antileukotrienes in Upper Airway Inflammatory Diseases

  2015cites this paper
• Montelukast As An Adjunct To Treatment of Chronic Rhinosinusitis With Polyposis: A Prospective Randomized Controlled Trial

  2015cites this paper
• Medical Therapies for Adult Chronic Sinusitis: A Systematic Review.

  2015cites this paper
• A real – life observational pilot study to evaluate the effects of two-week treatment with montelukast in patients with chronic cough

  2014cites this paper
• Is montelukast indicated for treatment of chronic rhinosinusitis with polyposis?

  2014cites this paper
• Bambuterol versus Montelukast in Patients with Chronic Asthma

  2014cites this paper
• Impact of montelukast on asthma associated with rhinitis, and other triggers and co-morbidities

  2014cites this paper
• Die adaptive Desaktivierungsbehandlung bei Patienten mit ASS-Intoleranz- Syndrom: Übersicht über ein ursächlich- orientiertes Therapieprinzip

  2014cites this paper
• Substance P and neurokinin 1 receptors as potential therapeutic targets in children with OSA.

  2014cites this paper
• Modulation of respiratory mucosal immunity against pulmonary tuberculosis

  2014cites this paper
• Evidence-based Treatment of Chronic Rhinosinusitis with Nasal Polyps

  2013cites this paper
• Leukotriene antagonists in nasal polyposis: A meta-analysis and systematic review

  2013cites this paper
• Leitlinie „Rhinosinusitis“ – Langfassung

  2012cites this paper
• Immunomodulatory treatments for aspirin exacerbated respiratory disease

  2012cites this paper
• Leukotriene Inhibitors in Sinusitis

  2012cites this paper
• Role of Leukotriene Receptor Antagonists in the Management of Pediatric Asthma

  2012cites this paper
• Montelukast and Maintenance of Steroid-Induced Remission in Eosinophilic Esophagitis

  2011cites this paper
• Pharmacokinetic Analysis of Montelukast in Healthy Korean Volunteers by High Performance Liquid Chromatography-Tandem Mass Spectrometry

  2011cites this paper
• Journal of Asthma and Allergy Dovepress Nasal Polyps in Patients with Asthma: Prevalence, Impact, and Management Challenges

  year unknowncites this paper